Drugs that target wakefulness, molecules in cannabis and wearable devices that modulate brain activity could help insomniacs ...

Pfizer jumps into cancer-treatment race with a $6 billion licensing deal with a China-based company, six months after Merck’s ...

Phase 3 clinical trial of BNC-210 in social anxiety disorder on track for topline readout in Q3 2025α7 nicotinic ...

People need healthcare products and services regardless of what's happening with the economy. Which healthcare stocks could ...

AstraZeneca AZN stock has declined 6.4% in the past three months. Although AstraZeneca faces its share of challenges, a ...

A pragmatic approach to streamlining technology and innovating processes will help advance clinical data management.

Just before dawn in Taicang, a county-level city in East China's Suzhou, Jiangsu province, hot dough at Brotecke — a beloved ...

Antimicrobial-resistant (AMR) “superbugs” contribute to more than 4.5 million deaths globally per year and threaten to make ...

The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its ...

Seek AI, the trusted AI agent platform for data, today announced that Vicci Eyewear has selected the Seek AI platform to power its data strategy for online retail growth. Vicci Eyewear, a Miami-based ...

The AltStar Awards, celebrating its fourteenth year as the premier recognition event for alternative culture, announces its 2025 event schedule including the third annual AltStar Expo featuring an all ...

Pfizer has the FDA approval it was seeking for Prevnar 20, the latest update to its blockbuster pneumococcal vaccination franchise, keeping it one step ahead of a competing shot from Merck & Co.